DRNO - Daily Research News
News Article no. 40626
Published November 18 2026

 

 

 

$15 Million Raise for Pharma Intelligence Firm ODAIA

Toronto-based predictive pharma intelligence company ODAIA has announced a $15 million Series C round of financing, earmarked for further development of its platform and for growth 'within the enterprise pharma accounts it already serves.'

Philip PoulidisODAIA was founded out of the University of Toronto in 2018 and is headquartered in the Canadian city, with an office in Boston, USA. Its solutions are used by pharma firms to understand patient journeys, uncover missed Rx opportunities, determine which HCPs to prioritize through which channels, coordinate cross-channel sales and marketing, and to build and hone workflow automations for field and marketing teams across many therapeutic areas.

ODAIA says that inside most pharma companies, data sits in many systems owned by separate teams, so brand, marketing, and field each work from a different picture of the same physician. The firm's commercial intelligence platform brings disparate data, field sales activity, and digital engagement into one view of each HCP that brand, marketing and field teams all work from. The firm claims its decision engine 'identifies physicians whose patients are likely to need a therapy, often months before a diagnosis shows up in the data,' and guides the approach to the most appropriate HCP targets.

The round was led by Monograph Capital and anchored by strategic investor PHM, the health media agency within Publicis Groupe. Existing investors BDC Capital, Flint Capital, Innospark Ventures, Graphite Ventures, Threshold Ventures and Wittington Ventures also participated.

Alongside the financing, ODAIA signed a commercial Platform Agreement that makes PHM, Publicis Groupe's US health media agency, its exclusive agency partner in the country.

'Pharma has proven that AI works in commercial,' says ODAIA CEO and co-founder Philip Poulidis (pictured). 'The hard part now is scaling it. Most companies can show results on one brand, and every new brand or therapeutic area still costs another team and another build. ODAIA started by helping field teams decide where to focus. Today our platform is the commercial intelligence infrastructure that scales what's working across brand, marketing, and field teams, and across a company's whole portfolio. This round lets us go deeper with the enterprise customers we already serve and, with PHM, bring that infrastructure to more of the industry, faster.'

Web site: www.odaia.ai .

 

 
www.mrweb.com/drno - Daily Research News Online is part of www.mrweb.com

Please email drnpq@mrweb.com with any questions.

Back to normal version.

© MrWeb Ltd